NCT04650321View on ClinicalTrials.gov

Home Based Infusions for Ocrelizumab

PHASE4RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions

Multiple Sclerosis

Interventions

DRUG

Ocrelizumab at home

Patients will receive ocrelizumab infusion at home.

Trial Locations (1)

80112

RECRUITING

Amerita, Centennial

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Colorado, Denver

OTHER